ONCOLOGY

A new research collaboration between Monash University and Lava Therapeutics details a novel immune-oncology approach for the potential treatment of cancer. The new findings will serve as a model…

According to new studies discussed at the ESMO Virtual Congress 2020, Delays and cancellation of cancer treatments and other safety measures undertaken to minimise the risk of exposure to the…

Interim data from a Phase 3 trial shows that Opdivo (nivolumab) significantly prolongs the time patients with resected esophageal or gastroesophageal junction cancer live without signs of disease…

M. Co et.al. presented a study understand the association of breast implants and anaplastic large cell lymphoma as such an association has aroused public health concerns on breast implant safety.…

Tetsuro Kawagoe et.al. present a case of a 63-year-old woman was admitted to our institution for severe pain in her right lower abdomen caused by the perforation of cecal cancer. She underwent…

In patients with non–small cell lung cancer (NSCLC), a continuous rise in clinically relevant driver mutations has been seen over the years, and, due to the development of effective treatments,…

In patients with non–small cell lung cancer (NSCLC), a continuous rise in clinically relevant driver mutations has been seen over the years, and, due to the development of effective treatments,…

According to the latest update Oncologists in the long-running I-SPY 2 platform trial are training physicians from across the United States who treat acute respiratory distress syndrome on how to…